Literature DB >> 8589770

Changes in lean body mass in obese children during a weight reduction program: effect on short term and long term outcome.

J Schwingshandl1, M Borkenstein.   

Abstract

OBJECTIVE: To study the changes in body composition during a weight reduction program in obese children and adolescents.
DESIGN: A short-term longitudinal study.
SUBJECTS: Forty-one obese children and adolescents (19 M, 22F, age 8.5-14.8 [median 11.8] years. MEASUREMENTS: Lean body mass (LBM) was estimated from Resistance Index (RI) obtained by Bioelectrical Impedance Analysis (BIA) before and after the 3 week program.
RESULTS: Mean percentage weight for height at baseline was 151 (s.d. 20)% and significantly decreased at the end of the three weeks (139 (s.d. 18)%, P = 0.005). The mean percentage body fat also decreased (from 46.0 s.d. 5.8% to 41.5 s.d. 6.5%, P = 0.0015). All individuals lost body fat during the three weeks, whereas the change in LBM was heterogeneous. The individual change in body fat was inversely correlated with the change in LBM (r = -0.64, P = 0.0001). After 4 months, 18 out of the 41 children could be reevaluated for height and weight. The regain in body weight during these 4 months was inversely correlated with the change in LBM during the weight reduction program (r = -0.55, P = 0.018).
CONCLUSIONS: Changes in LBM during a weight reduction program can predict the short term result those children who manage to increase LBM having the greatest reduction in body fat. Changes in LBM during weight reduction seem also to predict the longterm outcome, a reduction in LBM being associated with greater regain of weight. Weight reduction programs for obese children should focus not only on weight loss but also on maintenance or increase of lean body mass to improve longterm results.

Entities:  

Mesh:

Year:  1995        PMID: 8589770

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  8 in total

1.  Effect of an individualised training programme during weight reduction on body composition: a randomised trial.

Authors:  J Schwingshandl; K Sudi; B Eibl; S Wallner; M Borkenstein
Journal:  Arch Dis Child       Date:  1999-11       Impact factor: 3.791

2.  Effects of weight loss on leptin, sex hormones, and measures of adiposity in obese children.

Authors:  K M Sudi; S Gallistl; M H Borkenstein; D Payerl; R Aigner; R Möller; E Tafeit
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

3.  One-year increment of fat mass and lean body mass of Japanese school children using bioelectrical impedance.

Authors:  K Kida; Y Nishizawa; K Saito; H Nakamura; H Fukuda; M Ishida; Y Kimura; R Mita
Journal:  Environ Health Prev Med       Date:  1998-10       Impact factor: 3.674

4.  Effect of a 3-week body mass reduction program on body composition, muscle function and motor performance in pubertal obese boys and girls.

Authors:  N A Maffiuletti; A De Col; F Agosti; S Ottolini; D Moro; M Genchi; M Massarini; C L Lafortuna; A Sartorio
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

5.  Change in body composition during a weight loss trial in obese adolescents.

Authors:  E P Parks; B Zemel; R H Moore; R I Berkowitz
Journal:  Pediatr Obes       Date:  2013-02-05       Impact factor: 4.000

Review 6.  Treatment of adolescent overweight and obesity.

Authors:  Margarita D Tsiros; Natalie Sinn; Alison M Coates; Peter R C Howe; Jonathan D Buckley
Journal:  Eur J Pediatr       Date:  2007-11-01       Impact factor: 3.183

7.  Changes in fat mass, fat-free mass and aerobic fitness in severely obese children and adolescents following a residential treatment programme.

Authors:  Benedicte Deforche; Ilse De Bourdeaudhuij; Patrick Debode; Freddy Vinaimont; Andrew P Hills; Stefanie Verstraete; Jacques Bouckaert
Journal:  Eur J Pediatr       Date:  2003-06-13       Impact factor: 3.183

8.  Aerobic exercise in adolescents with obesity: preliminary evaluation of a modular training program and the modified shuttle test.

Authors:  Peter H C Klijn; Olga H van der Baan-Slootweg; Henk F van Stel
Journal:  BMC Pediatr       Date:  2007-04-19       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.